HIV and AIDS Trial, Recruiting (NCT06743204)

HIV and AIDS Trial, Recruiting NCT06743204 Sponsor: Johns Hopkins University Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT06743204 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Sexually active females between the ages of 15 and 39 years old
People who live in communities that are part of the Rakai Community Cohort Study (RCCS) and who took part in the most recent RCCS survey, regardless of HIV status
Pregnant women are also included
People who agreed, during their most recent RCCS survey, to have their blood plasma samples stored and tested
People who previously agreed to be contacted again for future studies
People who are willing to be randomly assigned to a group as part of this trial

Who may not be able to join:

People who are not able to give their own informed consent to participate
People who do not meet all of the inclusion criteria listed above

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mary Kathryn Grabowski, Associate Professor, PhD, Johns Hopkins School of Medicine

Phone: 443-287-5736

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06743204

Sponsor: Johns Hopkins University

Phase: Not Applicable

Status: Recruiting

Condition: HIV and AIDS

Trial contact: 443-287-5736

More information: https://clinicaltrials.gov/study/NCT06743204

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Sexually active females between the ages of 15 and 39 years old
People who live in communities that are part of the Rakai Community Cohort Study (RCCS) and who took part in the most recent RCCS survey, regardless of HIV status
Pregnant women are also included
People who agreed, during their most recent RCCS survey, to have their blood plasma samples stored and tested
People who previously agreed to be contacted again for future studies
People who are willing to be randomly assigned to a group as part of this trial

Who may not be able to join:

People who are not able to give their own informed consent to participate
People who do not meet all of the inclusion criteria listed above

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Johns Hopkins University

Registry

ClinicalTrials.gov

Start date

8 September 2025

Est. completion

31 January 2028

Where this trial is recruiting

Uganda

Primary endpoints

PreP uptake; PreP adherence; PreP persistence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov